About Ideal Cures


Ideal Cures (IC) is one of India’s leading manufacturer and exporter of pharmaceutical excipients and ready-to-use coating systems for solid oral dosage forms. IC provides tailor-made solutions and products for the pharmaceutical and allied industries, through a network of customers and partners across more than 40 countries around the world. Leveraging over three decades of coating experience, technical know-how and expertise Ideal Cures’ provides precise, simplified solutions uniquely shaped to meet a customer’s requirements.


IC provides its customers with a complete range of coating products and excipients complemented by technical and regulatory services. IC’s product portfolio includes INSTACOAT® ready-to-use film coating systems, ECOPOL® range of Pharma Acrylic Polymer’s, ECOCOOL® brand of cooling compounds, ESPHERES™ range of microcrystalline cellulose, silicon dioxide, calcium carbonate, tartaric acid spheres, new generation of sugar spheres and INSTANUTE® coating technology for nutraceuticals and dietary supplements.

IC is the first film coating company to have all its cGMP compliant manufacturing plants EXCiPACT™ certified. IC’s latest manufacturing facility in Sikkim will be certified in due course. An ISO 9001:2015 certified company with a US DMF for all its certified manufacturing facilities. IC is one of the most

innovative film-coating companies. IC has 11 granted patents and 8 pending grants for its film-coating products, specialised excipients and R&D coating machines.


Technical Support at every stage:

IC’s teams are continuously innovating and exploring methods and techniques for process optimization at their technologically advanced Research and Development centres and Application laboratories across the world. IC’s young and enthusiastic team of technical and regulatory scientists function as their customer’s “extended team”, supporting them at every step, right from formulation development to post-commercialization.


For a comprehensive, time-saving tablet coating experience, Talk to Us!

Ideal Cures’ Recent Events

CPhI India – India Pharma Week, Nov 28 – 30, 2017

IDEAL CURES’ INSTACOAT 4G bags recognition

Ideal Cures’ INSTACOAT 4G was declared the winner at India Pharma Awards 2017 for ‘Excellence in R&D – Development of new product/ technology.’ INSTACOAT 4G innovation is credit to innovation by indigenous scientists at Ideal Cures, with two research and development centres.

Suresh Pareek, MD, Ideal Cures said, “INSTACOAT 4G was formulated with the aim of supporting customer expectations to push the productivity levels and giving them advantages that they wanted to fathom. INSTACOAT 4G can be reconstituted at 35 per cent solids, resulting in significantly reducing the carbon footprint, making it a stand-apart environmentally friendly product. With a massive reduction in coating process time, the pharma industry saves on energy consumption costs, triples production output, gets the advantage of moisture barrier properties and reduces their machine occupancy times delaying capital costs.”

This sustainable idea, planned and executed over a period of two years, INSTACOAT 4G is here to deliver for the present and the future for a long time to come. Maximising the potential of batch and continuous coaters, various pharmaceutical and allied businesses have successfully commercialised this innovation globally.

Ideal Cures Cphi pharma award finalist

CPhI World Wide

October 24-27, Frankfurt, Germany


An innovative tablet coating formulation capable of reducing coating process time, energy and cost while maximizing the potential of continuous and batch coaters of any size, is certain to take center stage. INSTACOAT 4G stands today as a finalist for the CPhI Pharma Excellence Awards 2017 – Excipient Category. Visit the Ideal Cures team at our Booth 102B91 from 24th – 26th October 2017 to understand how this formulation can help you earn carbon credits and double your production output.


Formulation Development and Drug Delivery (FDD) Conclave

June 16-17, 2017, Hyderabad


An inaugural session, the first FDD Conclave 2017 was held in Hyderabad on 16 and 17 June 2017. A two-day congregation of industry-wide R&D leaders, the event sponsored by Ideal Cures, saw insightful panel discussions and sessions on novel solutions that the coating industry had to offer. The FDD Leadership Awards 2017 recognized and felicitated R&D scientists for their efforts towards bringing in new drug therapies and formulation systems. A foundation building platform, this conclave is all set to take place every year!


You can read about all the happenings of this event in Express Pharma’s July 2017 issue


Product Portfolio



Ideal Cures Product Catalogue
IDEAL CURES Product Brochure.pdf
Adobe Acrobat Document 3.6 MB


HPMC Copovidone Article – Ideal Cures.pd
Adobe Acrobat Document 925.9 KB


Evaluation of Capric glycerides as an an
Adobe Acrobat Document 1.4 MB

AAPS 2017 Posters